Calprotectin and Receptor for Advanced Glycation End Products as a Potential Biomarker in Abdominal Aortic Aneurysm
Experiments conducted in recent years on animals and research works worldwide show a linkage between calprotectin and occurrence and development of the abdominal aortic aneurysm (AAA). Additionally, a correlation between the level of the receptor for advanced glycation end products (RAGE) and the di...
Main Authors: | Willy Hauzer, Wojciech Witkiewicz, Jan Gnus |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/4/927 |
Similar Items
-
Relationship between the Levels of Calprotectin and Soluble Receptor for Advanced Glycation End Products with Abdominal Aortic Aneurysm Diameter: A Preliminary Clinical Trial
by: Willy Hauzer, et al.
Published: (2022-09-01) -
Treatment With Small Molecule Inhibitors of Advanced Glycation End‐Products Formation and Advanced Glycation End‐Products‐Mediated Collagen Cross‐Linking Promotes Experimental Aortic Aneurysm Progression in Diabetic Mice
by: Yankui Li, et al.
Published: (2023-05-01) -
Pathogenesis of abdominal aortic aneurysms from the vascular surgeon perspective – knowledge summary
by: Willy Hauzer, et al.
Published: (2022-12-01) -
Giant abdominal aortic aneurysms
by: Joshua I. Ng, BSE, et al.
Published: (2021-12-01) -
Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
by: Kosuke Saku, et al.
Published: (2020-07-01)